Although the NGS test did not either detect somatic mutations in the MSH6 locus even more than 100X coverage or characterized this tumor as hypermutated (tumor mutation burden was 6.8 mutations per mega base), another explanation for the loss of MSH6 could be that a small number of tumor cells carry isolated somatic mutations in the MSH6 genes. The gene discussed is MSH6; the disease is neoplasm.